4.8 Review

The cytokine network in acute myeloid leukemia

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Osteopontin is required for the maintenance of leukemia stem cells in acute myeloid leukemia

Jing Zhou et al.

Summary: This study reveals the crucial role of osteopontin (OPN) in acute myeloid leukemia (AML), showing that OPN contributes to the maintenance of leukemia stem cells (LSCs) by preventing apoptosis and cell cycle arrest. Therefore, OPN could be a potential therapeutic target for AML treatment.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)

Article Oncology

Release of IFN? by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells

Giulia Corradi et al.

Summary: The release of IFN gamma by AML cells induces a regulatory program in MSCs, leading to the induction of Treg in the bone marrow immune environment, contributing to an immuno-tolerant microenvironment of AML.

CLINICAL CANCER RESEARCH (2022)

Article Pharmacology & Pharmacy

The contributory roles of the CXCL12/CXCR4/CXCR7 axis in normal and malignant hematopoiesis: A possible therapeutic target in hematologic malignancies

Mahdieh Mehrpouri

Summary: CXCL12/CXCR4 and CXCL12/CXCR7 axes play a key role in hematopoiesis and their aberrant expression may lead to the development of leukemia. Various therapeutic interventions have been developed to target these axes in leukemic cells, showing promising results in pre-clinical and clinical studies.

EUROPEAN JOURNAL OF PHARMACOLOGY (2022)

Article Oncology

IL-6 promotes chemoresistance via upregulating CD36 mediated fatty acids uptake in acute myeloid leukemia

Yanjie Zhang et al.

Summary: This study revealed that interleukin-6 (IL-6) enhances lipid metabolism in skeletal muscle cells, thereby promoting chemoresistance in acute myeloid leukemia (AML). The mechanism involves IL-6-induced fatty acid (FA) uptake through stat3/CD36 pathway. Blocking CD36 can enhance the effect of chemotherapy drugs, representing a promising strategy for AML therapy.

EXPERIMENTAL CELL RESEARCH (2022)

Article Biochemistry & Molecular Biology

Interleukin-4 treatment reduces leukemia burden in acute myeloid leukemia

Fenghua Qian et al.

Summary: Interleukin-4 (IL-4) plays a therapeutic role in acute myeloid leukemia (AML) by alleviating the severity of the disease. IL-4 enhances the expression of hematopoietic- PGD(2) synthase (H-PGDS) to increase the production of endogenous cyclopentenone prostaglandins (CyPGs), leading to apoptosis of leukemia-initiating cells (LICs).

FASEB JOURNAL (2022)

Article Oncology

Regulatory T cells promote the stemness of leukemia stem cells through IL10 cytokine-related signaling pathway

Yingxi Xu et al.

Summary: Tregs can promote the stemness of AML cells through IL10 activation of the PI3K/AKT pathway, and blocking the IL10/IL10R/PI3K/AKT signal can reduce the stemness of AML cells. The interaction between Tregs and AML cells may be a new approach to target LSCs in AML treatment.

LEUKEMIA (2022)

Article Immunology

ILC1s control leukemia stem cell fate and limit development of AML

Zhenlong Li et al.

Summary: ILC1s can control acute myeloid leukemia by promoting leukemia stem cell apoptosis and favoring their differentiation into non-leukemic cells through the production of interferon-gamma. These findings provide a potential strategy for AML immunotherapy.

NATURE IMMUNOLOGY (2022)

Article Cardiac & Cardiovascular Systems

TET2-Driven Clonal Hematopoiesis and Response to Canakinumab An Exploratory Analysis of the CANTOS Randomized Clinical Trial

Eric C. Svensson et al.

Summary: This study investigated whether individuals with CHIP have a greater reduction in cardiovascular events in response to IL-1 beta neutralization therapy.

JAMA CARDIOLOGY (2022)

Review Oncology

Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia

Xingcheng Yang et al.

Summary: Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) are clonal hematopoietic stem cell diseases that arise from the bone marrow. Dysregulated immune microenvironment, including the molecules PD-1 and PD-L1, play important roles in the pathogenesis of MDS and AML. However, clinical trials using PD-1/PD-L1 inhibitors have reported mixed responses in patients with these diseases.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2022)

Article Oncology

Expression Levels of Il-6 and Il-18 in Acute Myeloid Leukemia and Its Relation with Response to Therapy and Acute GvHD After Bone Marrow Transplantation

Mahdiyar Iravani Saadi et al.

Summary: This study evaluated the expression levels of IL-6 and IL-18 in AML patients and found that the expression levels of these cytokines were associated with treatment response and GvHD. Higher levels of IL-6 and IL-18 were observed in patients without response to treatment or experiencing aGvHD after bone marrow transplantation.

INDIAN JOURNAL OF SURGICAL ONCOLOGY (2021)

Article Oncology

A new cytokine-based dynamic stratification during induction is highly predictive of survivals in acute myeloid leukemia

Pierre Peterlin et al.

Summary: This study aimed to assess the potential impact of serum cytokines kinetics during induction in AML patients and proposed a new risk stratification based on the kinetic profiles of FL and IL-6 to predict survival outcomes.

CANCER MEDICINE (2021)

Review Cell Biology

The Bone Marrow Microenvironment Mechanisms in Acute Myeloid Leukemia

Debora Bifano Pimenta et al.

Summary: Bone marrow is a complex tissue that regulates hematopoiesis, with AML developing in this microenvironment. Cells and molecules within the hematopoietic niche interact to influence leukemia development, suggesting that targeting the bone marrow microenvironment could be a promising strategy for AML treatment.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Chemistry, Medicinal

The Potential Advantage of Targeting Both PD-L1/PD-L2/PD-1 and IL-10-IL-10R Pathways in Acute Myeloid Leukemia

Laura Jimbu et al.

Summary: Tumor cells promote suppression of host anti-tumor responses by upregulating inhibitory molecules like PD-L1 and producing immunosuppressive cytokines like IL-10. Blocking PD-L1 and IL-10 may be a promising immunotherapeutic approach for AML patients.

PHARMACEUTICALS (2021)

Article Hematology

CD44 loss of function sensitizes AML cells to the BCL-2 inhibitor venetoclax by decreasing CXCL12-driven survival cues

Xiaobing Yu et al.

Summary: CD44 plays a crucial role in resistance to venetoclax-based therapies in AML, affecting the effects of CXCL12 and the expression of stem cell core transcription factors.

BLOOD (2021)

Review Biochemistry & Molecular Biology

CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies

Tripti Khare et al.

Summary: Chemokines like CXCL12 play a significant role in cancer growth and metastasis, with receptors like CXCR4 and CXCR7 being potential targets for treatment strategies in colorectal cancer. Targeting the CXCL12-CXCR4/CXCR7 axis shows promise in developing new therapies for CRC.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Oncology

Targeting of IL-10R on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells

Nianci Chen et al.

Summary: IL-10R targeted CAR-T therapy shows promising cytotoxic effects against AML cells and provides a new treatment strategy to improve the prognosis of AML.

BLOOD CANCER JOURNAL (2021)

Article Multidisciplinary Sciences

Clinical and prognostic relevance of CXCL12 expression in acute myeloid leukemia

Shi-sen Wang et al.

Summary: The study found that CXCL12 expression is significantly reduced in AML, and low CXCL12 expression is correlated with worse prognosis, predicting decreased overall survival and event-free survival rates.

PEERJ (2021)

Article Oncology

PD-1 and TIGIT Are Highly Co-Expressed on CD8+ T Cells in AML Patient Bone Marrow

Ling Xu et al.

Summary: The study comprehensively compared the distribution of PD-1 and TIGIT in PB and BM T cells from AML patients, finding a higher percentage of PD-1 and TIGIT single-positive CD8(+) T cells in elderly patients and a higher frequency of PD-1(+) and TIGIT(+) CD8(+) T cells in the BM compared to PB in both DN and R/R patients. This suggests a greater impairment of T cell function in elderly patients and a more immunosuppressive microenvironment in leukemia BM that may promote disease progression.

FRONTIERS IN ONCOLOGY (2021)

Review Cell Biology

Macrophages in Acute Myeloid Leukaemia: Significant Players in Therapy Resistance and Patient Outcomes

Katerina E. Miari et al.

Summary: This review discusses the potential links between macrophages, the development of therapy resistance, and patient outcomes in AML. It specifically focuses on AML cell reprogramming of macrophages, macrophage-driven activation of anti-cell death pathways in AML cells, and the association between macrophage phenotypes and clinical outcomes in AML. The therapeutic targeting of macrophages to overcome therapy resistance in AML and the use of genomic and proteomic-based approaches to address challenges in this research field are also highlighted.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Hematology

The IL1-IL1RAP axis plays an important role in the inflammatory leukemic niche that favors acute myeloid leukemia proliferation over normal hematopoiesis

Bauke De Boer et al.

Summary: Research found that high expression of IL1RAP is associated with AML and plays a significant role in AML cell proliferation. Stimulation with IL1I3 induces multiple chemokines and inflammatory secretome in IL1RAP-expressing AML cells, affecting normal hematopoietic stem cells.

HAEMATOLOGICA (2021)

Review Hematology

Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia

Eleni E. Ladikou et al.

BRITISH JOURNAL OF HAEMATOLOGY (2020)

Review Hematology

How I investigate acute myeloid leukemia

Damodaran Narayanan et al.

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2020)

Letter Oncology

Expression patterns of immune checkpoints in acute myeloid leukemia

Cunte Chen et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

Article Cell Biology

IL-6 blockade reverses bone marrow failure induced by human acute myeloid leukemia

Tian Yi Zhang et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Article Biotechnology & Applied Microbiology

Levels and Clinical Significance of Regulatory B Cells and T Cells in Acute Myeloid Leukemia

Qiaofeng Dong et al.

BIOMED RESEARCH INTERNATIONAL (2020)

Review Oncology

Targeting CXCR4 in AML and ALL

Daniel Cancilla et al.

FRONTIERS IN ONCOLOGY (2020)

Review Pharmacology & Pharmacy

The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer

Yi Shi et al.

FRONTIERS IN PHARMACOLOGY (2020)

Review Immunology

Tumor-Associated Macrophages in Tumor Immunity

Yueyun Pan et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Cell Biology

Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans

Franziska M. Uhl et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Article Medicine, General & Internal

Innate immunity, inflammation and tumour progression: double-edged swords

A. Mantovani et al.

JOURNAL OF INTERNAL MEDICINE (2019)

Article Biochemistry & Molecular Biology

Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation

Cristina Toffalori et al.

NATURE MEDICINE (2019)

Review Biochemistry & Molecular Biology

Acute Myeloid Leukemia Mutations: Therapeutic Implications

Cristina Papayannidis et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Biochemistry & Molecular Biology

Role of CXCL12 and CXCR4 in the pathogenesis of hematological malignancies

Amnon Peled et al.

CYTOKINE (2018)

Review Immunology

Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion

Flavia Castro et al.

FRONTIERS IN IMMUNOLOGY (2018)

Review Biochemistry & Molecular Biology

Innate Lymphoid Cells: 10 Years On

Eric Vivier et al.

Review Biochemistry & Molecular Biology

The cytokine network in acute myeloid leukemia (AML): A focus on pro- and anti-inflammatory mediators

Stephanie Binder et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2018)

Article Oncology

MIF-Induced Stromal PKCβ/IL8 Is Essential in Human Acute Myeloid Leukemia

Amina M. Abdul-Aziz et al.

CANCER RESEARCH (2017)

Review Oncology

Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer

Alireza Nazari et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2017)

Article Hematology

Regulation of normal and leukemic stem cells through cytokine signaling and the microenvironment

Virginia Camacho et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)

Review Immunology

Regulation of Inflammation- and Infection-Driven Hematopoiesis

Steffen Boettcher et al.

TRENDS IN IMMUNOLOGY (2017)

Article Cell Biology

Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression

Angel Garcia-Diaz et al.

CELL REPORTS (2017)

Review Medicine, General & Internal

Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside

Byung-Sik Cho et al.

KOREAN JOURNAL OF INTERNAL MEDICINE (2017)

Review Oncology

Inflammatory Signaling Pathways in Preleukemic and Leukemic Stem Cells

Shayda Hemmati et al.

FRONTIERS IN ONCOLOGY (2017)

Review Hematology

Molecular biomarkers in acute myeloid leukemia

Jeanette Prada-Arismendy et al.

BLOOD REVIEWS (2017)

Review Hematology

PD-1 signaling and inhibition in AML and MDS

Faysal Haroun et al.

ANNALS OF HEMATOLOGY (2017)

Article Medicine, Research & Experimental

AML-induced osteogenic differentiation in mesenchymal stromal cells supports leukemia growth

V. Lokesh Battula et al.

JCI INSIGHT (2017)

Review Hematology

Targeting the interleukin-1 pathway in patients with hematological disorders

Charlotte E. M. de Mooij et al.

BLOOD (2017)

Review Oncology

Acute myeloid leukemia: a comprehensive review and 2016 update

I. De Kouchkovsky et al.

BLOOD CANCER JOURNAL (2016)

Review Cell & Tissue Engineering

Normal and Leukemic Stem Cell Niches: Insights and Therapeutic Opportunities

Koen Schepers et al.

CELL STEM CELL (2015)

Review Oncology

Targeting IL4/IL4R for the treatment of epithelial cancer metastasis

Katherine Venmar Bankaitis et al.

CLINICAL & EXPERIMENTAL METASTASIS (2015)

Review Hematology

A hostel for the hostile: the bone marrow niche in hematologic neoplasms

Daniela S. Krause et al.

HAEMATOLOGICA (2015)

Article Oncology

Regulatory T cells-derived IL-35 promotes the growth of adult acute myeloid leukemia blasts

Qianshan Tao et al.

INTERNATIONAL JOURNAL OF CANCER (2015)

Article Medicine, Research & Experimental

IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia

Gerardo Musuraca et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2015)

Review Cell Biology

Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms

Gregor Hoermann et al.

MEDIATORS OF INFLAMMATION (2015)

Review Medicine, General & Internal

Acute Myeloid Leukemia

Hartmut Doehner et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Multidisciplinary Sciences

Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis

Georg F. Weber et al.

SCIENCE (2015)

Review Chemistry, Medicinal

Siltuximab (CNTO 328): a promising option for human malignancies

Runzhe Chen et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2015)

Article Multidisciplinary Sciences

IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia

Alexander Kuett et al.

SCIENTIFIC REPORTS (2015)

Article Biotechnology & Applied Microbiology

Bone Marrow Cells in Acute Lymphoblastic Leukemia Create a Proinflammatory Microenvironment Influencing Normal Hematopoietic Differentiation Fates

Armando Vilchis-Ordonez et al.

BIOMED RESEARCH INTERNATIONAL (2015)

Review Hematology

A hostel for the hostile: the bone marrow niche in hematologic neoplasms

Daniela S. Krause et al.

HAEMATOLOGICA (2015)

Review Pharmacology & Pharmacy

Osteopontin as a therapeutic target for cancer

Monalisa Bandopadhyay et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2014)

Review Pharmacology & Pharmacy

Targeting interleukin-6 in inflammatory autoimmune diseases and cancers

Xin Yao et al.

PHARMACOLOGY & THERAPEUTICS (2014)

Article Cell Biology

IL-6 in Inflammation, Immunity, and Disease

Toshio Tanaka et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)

Article Immunology

Next-generation dendritic cells for immunotherapy of acute myeloid leukemia

Frauke Schnorfeil et al.

Journal for ImmunoTherapy of Cancer (2014)

Article Medicine, Research & Experimental

The role of the CXCL12-CXCR4/CXCR7 axis in the progression and metastasis of bone sarcomas

Yu-Xin Liao et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)

Article Medicine, Research & Experimental

CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia

Ye Chen et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Review Chemistry, Medicinal

Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in Cancer

Laura M. Campbell et al.

PHARMACEUTICALS (2013)

Article Anatomy & Morphology

The Prognostic Value of CXCR4 in Acute Myeloid Leukemia

Jeong Yeal Ahn et al.

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2012)

Review Immunology

Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response

Katherine Y. King et al.

NATURE REVIEWS IMMUNOLOGY (2011)

Article Oncology

CXCL12 (SDF-1)/CXCR4 Pathway in Cancer

Beverly A. Teicher et al.

CLINICAL CANCER RESEARCH (2010)

Article Immunology

Direct inhibition of human acute myeloid leukemia cell growth by IL-12

Elisa Ferretti et al.

IMMUNOLOGY LETTERS (2010)

Article Multidisciplinary Sciences

Quiescent haematopoietic stem cells are activated by IFN-γ in response to chronic infection

Megan T. Baldridge et al.

NATURE (2010)

Review Immunology

The regulation of IL-10 production by immune cells

Margarida Saraiva et al.

NATURE REVIEWS IMMUNOLOGY (2010)

Article Multidisciplinary Sciences

IFNα activates dormant haematopoietic stem cells in vivo

Marieke A. G. Essers et al.

NATURE (2009)

Letter Hematology

Marrow osteopontin level as a prognostic factor in acute myeloid leukaemia

Cheng-Yeh Lee et al.

BRITISH JOURNAL OF HAEMATOLOGY (2008)

Article Immunology

TNF-alpha is critical to facilitate hemopoietic stem cell engraftment and function

Francine Rezzoug et al.

JOURNAL OF IMMUNOLOGY (2008)

Article Hematology

CXCR4 is a prognostic marker in acute myelogenous leukemia

Anke C. Spoo et al.

BLOOD (2007)

Article Oncology

Effects of interferon gamma on native human acute myelogenous leukaemia cells

Elisabeth Ersvaer et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)

Review Medicine, General & Internal

Acute myeloid leukaemia

Elihu Estey et al.

LANCET (2006)

Article Hematology

IL-6 blocks a discrete early step in lymphopoiesis

K Maeda et al.

BLOOD (2005)

Review Oncology

Leukemic cells and the cytokine patchwork

C Kiss et al.

PEDIATRIC BLOOD & CANCER (2004)

Review Biochemistry & Molecular Biology

IL-6 in autoimmune disease and chronic inflammatory proliferative disease

K Ishihara et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2002)

Review Biochemistry & Molecular Biology

Interleukin-8 and human cancer biology

KP Xie

CYTOKINE & GROWTH FACTOR REVIEWS (2001)